NKGen Biotech
About NKGen Biotech
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Common equity PIPE with warrants T: - FT: Common equity PIPE with warrants |
A: 2000000 MR: - FA: 2.0M FAN: 2000000 |
D: 2025-07-16 FD: 2025-07-16 |
1 investors |
| 2 |
RT: Equity T: - FT: Equity |
A: 2650000 MR: - FA: $2.65 million FAN: 2650000 |
D: 2025-05-08 FD: 2025-05-08 |
2 investors |
| 3 |
RT: Second Lien Convertible Loan T: - FT: Second Lien Convertible Loan |
A: 5000000 MR: - FA: $5 million FAN: 5000000 |
D: 2024-04-11 FD: 2024-04-11 |
- |
Growth Metrics
Team & Leadership
Paul Y. Song, MD
Chairman and Chief Executive Officer
Yong Man Kim, PhD
Chief Scientific Officer
James Graf
CFO (interim)
Michael Klowden
Board Member
Marco Gottardis, PhD
Board Member
Kathleen Scott
Board Member
Recent News
NKGen Biotech Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- nkgenbiotech.com
- Industries
- Biotechnology
- Company Size
- ~460 employees (est.)
- Locations
-
Santa Ana, California, USA
Santa Ana, Calif., USA
Santa Ana, Calif.
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro